Biblio Discovery — Demo Discovery Service

122 hasil

Menampilkan 1–20 · 0,32 detik · RSS

Jurnal

Annals of Urologic Oncology

ISSN 2617-7765 · Asian Medical Press Ltd.(H.K.) · 122 artikel di indeks

  1. Artikel Jurnal

    Targeting Cellular Senescence in Prostate Cancer: Molecular Landscape and Therapeutic Avenues

    Haneen Hossam; Bandar Alattaibi

    Annals of Urologic Oncology, Vol. 9 No. 2 · 2026 · Inggris · DOAJ

    Prostate cancer is one of the major causes of cancer morbidity and mortality in men, especially at advanced stages where treatment fails. Despite the fact that the existing treatment options, such as androgen deprivation therapy, chemotherapy, radiotherapy, PARP inhibitors, and targeted agents, can…

  2. Artikel Jurnal

    Adenoid Cystic (Basal Cell) Carcinoma of the Prostate: A Rare Entity with Diagnostic Challenges and Therapeutic Uncertainty

    Shabana Andleeb Ansari; Mohd. Mubashir Ali Khan; Azmat Kamal Ansari dkk.

    Annals of Urologic Oncology, Vol. 9 No. 1 · 2026 · Inggris · DOAJ

    Background Adenoid cystic carcinoma (ACC), also referred to as basal cell carcinoma (BCC) of the prostate— a term used synonymously in the literature to describe the same clinicopathological entity— is an exceedingly rare malignant neoplasm. Initially described in the salivary glands by Billroth in…

  3. Artikel Jurnal

    A Diagnostic Twist: Primary Bladder Adenocarcinoma Masquerading as an Ovarian Torsion: A Case Report on Unusual Cystic Presentation

    Sonali Kar; Neeta Verma; Suren Kumar Das

    Annals of Urologic Oncology, Vol. 8 · 2025 · Inggris · DOAJ

    Primary bladder adenocarcinoma (PBA) is a rare malignancy comprising of only 0.5–2% of all bladder cancers and typically presents with nonspecific urinary symptoms. Cystic presentation is extremely uncommon and can mimic other pelvic pathologies. We report a very rare case of PBA in a 40-year-old…

  4. Artikel Jurnal

    Incidentally Discovered Primary Renal Leiomyosarcoma in a Middle Aged Female Presenting with Symptoms of Incomplete Abortion: A Rare Case Report

    Rashi Maheshwari; Shikhar Chohan; Ayushi Agarwal dkk.

    Annals of Urologic Oncology, Vol. 8 · 2025 · Inggris · DOAJ

    Background Primary renal leiomyosarcoma (LMS) is an exceptionally rare malignant mesenchymal tumor, constituting

  5. Artikel Jurnal

    Synthetic Lethality in Prostate Cancer: Evaluating the Role of PARP Inhibitors in BRCA-Mutated mCRPC

    Xinliang Xu; Minna Liu

    Annals of Urologic Oncology, Vol. 8 · 2025 · Inggris · DOAJ

    Prostate cancer, a leading cause of cancer-related mortality in men, often progresses to metastatic castration-resistant prostate cancer (mCRPC) despite advances in treatment with androgen-receptor pathway inhibitors (ARPIs) and taxanes. Recent genomic studies have highlighted that alterations in…

  6. Artikel Jurnal

    Saliva-Based Polygenic Risk Scores and AI-Enhanced Imaging for Prostate Cancer Screening beyond PSA

    Fan Li; Xian Zhang

    Annals of Urologic Oncology, Vol. 8 · 2025 · Inggris · DOAJ

    Background Prostate-specific antigen (PSA) testing, long used for prostate cancer screening, is limited by poor specificity (~25%), leading to unnecessary biopsies in over 70% of cases and substantial healthcare costs. Methods This review synthesizes recent evidence (2023–2025) on emerging…

  7. Artikel Jurnal

    The Urological Subtleties of an Uncommon Encounter with Primary Mucinous Adenocarcinoma of the Urinary Bladder with Review of Literature

    Anuradha Pandit; Shaivy Malik; Nibir Chakma dkk.

    Annals of Urologic Oncology (2025) · 2025 · Inggris · DOAJ

    Primary mucinous adenocarcinoma (PMA) of the urinary bladder is a rare and aggressive neoplasm, accounting for 0.5-2% of bladder malignancies. We report a case of a 52-year-old male presenting with urinary obstructive symptoms and hematuria. Imaging revealed a bladder mass, and histopathology…

  8. Artikel Jurnal

    Metabolic Reprogramming in Kidney Cancer: Implications for Therapy

    Elena Tena Edo

    Annals of Urologic Oncology, Vol. 8 · 2025 · Inggris · DOAJ

    Kidney cancer, particularly clear cell renal cell carcinoma (ccRCC), has emerged as a paradigm for cancer metabolic reprogramming, exhibiting distinctive alterations that drive tumor progression and therapeutic resistance. This comprehensive review synthesizes current knowledge of the molecular…

  9. Artikel Jurnal

    The Concomitant Use of Angiotensin System Inhibitors Predicts Favorable Prognosis for Renal Cell Carcinoma Patients

    Shuenqin Hu; Xiuying Li

    Annals of Urologic Oncology, Vol. 8 · 2025 · Inggris · DOAJ

    Objective Previous data suggest that Angiotensin system inhibitors (ASIs) may exert antitumor effects; however, the findings remain controversial. Therefore, the present study was conducted to evaluate the association between concomitant use of ASIs and survival outcomes in patients with renal cell…

  10. Artikel Jurnal

    Using Artificial Intelligence to Advance Renal Cancer Diagnosis, Treatment, and Precision Medicine

    Darragh Walsh; Callum Hayes

    Annals of Urologic Oncology, Vol. 8 No. 2 · 2025 · Inggris · DOAJ

    Renal cancer (RC) ranks tenth among the most frequently diagnosed cancers and affects both men and women worldwide. This disease is a significant global health issue, highlighting the need for accurate and rapid diagnostic tools to guide treatment. Conventional pathological methods have drawbacks…

  11. Artikel Jurnal

    Evolving Therapeutic Paradigms in Bladder Cancer: the Impact of Immunotherapy and Antibody-Drug Conjugates

    Shahd Mustafa Ibrahim; Ahmed Attia Ahmed Abdelmoaty; Ahmed Helmy Abdelhaseb

    Annals of Urologic Oncology, Vol. 8 · 2025 · Inggris · DOAJ

    Bladder cancer is a significant global health challenge. Despite advances in surgery and platinum-based chemotherapy over the decades, limited improvements in clinical outcomes have been observed. However, recent years have witnessed the development of immune checkpoint inhibitors (ICIs) and…

  12. Artikel Jurnal

    Metabolic Supremacy Fuels Tumor Aggressiveness in Renal Cancer

    Reham Gholam; Muhammad Khalilzad

    Annals of Urologic Oncology, Vol. 8 No. 1 · 2025 · Inggris · DOAJ

    Renal cell carcinoma, with clear cell renal carcinoma (ccRCC) being the dominant form, is recognized as a malignancy driven by abnormal metabolic processes, with extensive alterations in glucose, lipid, and amino acid pathways. The loss of the Von Hippel-Lindau (VHL) gene in nearly 90% of ccRCC…

  13. Artikel Jurnal

    Advancements in Research on Non-AR- Signaling Pathways and Targeted Therapies for Castration-Resistant Prostate Cancer

    Haq Dad; Asger Hansen

    Annals of Urologic Oncology, Vol. 8 · 2025 · Inggris · DOAJ

    Prostate cancer (Pca) is a significant malignancy affecting men's health, with its incidence steadily increasing worldwide in recent years. Among its various subtypes, castration-resistant prostate cancer (CRPC) holds particular importance due to its pivotal role in the progression and management…

  14. Artikel Jurnal

    A Potential Role of MicroRNA in the Renal Cancer and Its Tumor Microenvironment

    Daniel Chikere Ali; Siva Bharath Merugu

    Annals of Urologic Oncology, Vol. 8 · 2025 · Inggris · DOAJ

    Renal cell carcinoma (RCC) accounts for approximately 2.2% of all diagnosed cancers and 1.8% of cancer-related deaths. Clear cell renal cell carcinoma (ccRCC) is the most prevalent subtype of RCC, accounting for approximately 70–80% of all cases. Despite significant advancements in therapeutic…

  15. Artikel Jurnal

    Involvement of Epidermal Growth Factor Receptor (EGFR) Signaling in Renal Cell Carcinoma Progression and Therapeutic Implication

    Ghulam Raza; Kareem Khan

    Annals of Urologic Oncology, Vol. 8 No. 1 · 2025 · Inggris · DOAJ

    Renal cell carcinoma (RCC) is the common type of kidney cancer linked to alteration of lipid, glucose, and amino acid metabolism. Early stage RCC has prognosis with overall 5-year survival rate of 90%, and the RCC has unfavorable prognosis when the disease metastasizes. Loss of or carrying mutated…

  16. Artikel Jurnal

    Role of Hyperbaric Oxygen Therapy in Prostate Tumor Microenvironment and Cancer Stem Cell Niche

    Pranathi Konda; Merrel Holley; Vinoth Kumar Lakshmanan

    Annals of Urologic Oncology, Vol. 7 No. 4 · 2025 · Inggris · DOAJ

    Hyperbaric oxygen therapy (HBOT), has gained attention in recent years as a potential adjunct to conventional cancer treatments, particularly in addressing tumor hypoxia which is extensively employed as a post-injury treatment, is the administration of >92% oxygen at 1.5- 3.0 ATA for 60-120…

  17. Artikel Jurnal

    Testicular Carcinoma: Molecular Pathogenesis, Diagnostic Advances, and Evolving Therapeutic Strategies

    Aadhira Aiyar; Alina Roos

    Annals of Urologic Oncology, Vol. 8 No. 4 · 2025 · Inggris · DOAJ

    Testicular carcinoma is the most common solid tumor in young male patients. Despite a high rate of survival, current treatments come with significant long-term toxicities, highlighting the need for more precise diagnostics and therapies. The current review focuses on the molecular pathogenesis…

  18. Artikel Jurnal

    Evolving Precision Therapy Paradigm against Adrenocortical Carcinoma

    Declan Moore; Wayway Li

    Annals of Urologic Oncology, Vol. 8 No. 4 · 2025 · Inggris · DOAJ

    Adrenocortical carcinoma (ACC) is a rare and highly aggressive endocrine cancer type, posing significant clinical challenges due to its diverse molecular features and poor treatment outcomes. At the molecular level, abnormalities in pathways, such as IGF2 signaling, Wnt/β-catenin activation…

  19. Artikel Jurnal

    Non-Histone Chromatin Protein Dysregulation: The Oncogenic Role of HMGB1 and Its Redox States in ccRCC Inflammation and Genome Instability

    Betty Alex

    Annals of Urologic Oncology, Vol. 8 No. 4 · 2025 · Inggris · DOAJ

    High Mobility Group Box 1 (HMGB1) is non-histone chromatin protein that plays important roles in maintaining nuclear architecture, transcriptional modulation, DNA replication, chromatin restructuring and DNA damage repair. In addition to its classical nuclear roles, HMGB1 predominantly functions as…

  20. Artikel Jurnal

    Prostate-Specific Membrane Antigen (PSMA) PET-CT: Revolutionizing Staging, Restaging, and Treatment Response Assessment

    Theo Smith; Mia Harper

    Annals of Urologic Oncology, Vol. 8 No. 4 · 2025 · Inggris · DOAJ

    Prostate-specific membrane antigen (PSMA) positron emission tomography–computed tomography (PET-CT), has become the benchmark imaging tool in the management of prostate cancer, due to its unparalleled precision in staging, restaging and assessing of treatment response. Traditional imaging…